QIM
INO icon

Quantitative Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

Quantitative Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,302
Closed -$479K – 495
2021
Q1 		$479K Buy
+4,302
New +$566K 0.04% 343
2020
Q1 		– Sell
-2,013
Closed -$79K – 668
2019
Q4 		$79K Buy
+2,013
New +$60.6K ﹤0.01% 606
2018
Q4 		– Sell
-1,833
Closed -$122K – 701
2018
Q3 		$122K Buy
+1,833
New +$102K ﹤0.01% 597
2017
Q1 		– Sell
-4,133
Closed -$344K – 793
2016
Q4 		$344K Buy
4,133
+350
+9% +$31.6K 0.01% 721
2016
Q3 		$423K Sell
3,783
-2,192
-37% -$242K 0.01% 561
2016
Q2 		$662K Sell
5,975
-567
-9% -$68.9K 0.03% 502
2016
Q1 		$683K Buy
+6,542
New +$505K 0.03% 483
2015
Q2 		– Sell
-1,308
Closed -$128K – 573
2015
Q1 		$128K Buy
+1,308
New +$127K 0.01% 582
2014
Q2 		– Sell
-717
Closed -$114K – 554
2014
Q1 		$114K Buy
717
+348
+94% +$50K 0.01% 500
2013
Q4 		$51K Buy
+369
New +$36.9K ﹤0.01% 545

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Quantitative Investment Management's INO Position: Q2 2021 in Review

Quantitative Investment Management sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 4,302 shares — an estimated $479K sold.

Quantitative Investment Management first reported a position in INO in Q4 2013 and held it in 10 quarters. The position peaked at $683K in Q1 2016. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Quantitative Investment Management reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 4,302 Inovio Pharmaceuticals shares in Q2 2021, an estimated $479K.
  • Quantitative Investment Management first reported a position in Inovio Pharmaceuticals in Q4 2013 and held it in 10 quarters.
  • Quantitative Investment Management's Inovio Pharmaceuticals position peaked at $683K in Q1 2016.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.